Shareholders to Vote on 84.76% Dilution and Massive Authorized Share Increase for Critical $80M Capital Raise

summarizeSummary

BayFirst Financial Corp. is seeking shareholder approval for the conversion of $80 million in preferred stock into common shares, which will result in 84.76% dilution for existing shareholders, and to increase authorized shares from 15 million to 100 million to enable this critical capital raise.

check_boxKey Events

• Shareholder Vote on Massive Dilution

  Shareholders will vote on July 14, 2026, to approve the conversion of Series D and E preferred stock, which will result in existing common shareholders owning approximately 15.24% of the company, representing 84.76% dilution.

• Approval for Authorized Share Increase

  A vote is required to amend the company's articles of incorporation to increase authorized common stock from 15,000,000 to 100,000,000 shares, necessary to facilitate the full conversion of the preferred stock.

• Critical Capital Infusion for Regulatory Compliance

  The $80 million private placement, which closed on April 28, 2026, was crucial for the company's subsidiary bank to comply with regulatory capital requirements and avoid formal enforcement action.

• Follow-on Shareholder Offering at Discounted Price

  Following the conversion, the company will launch a public offering of up to 4,108,072 common shares at $3.50 per share, exclusively for existing shareholders, matching the private placement's effective price.

auto_awesomeAnalysis

This preliminary proxy statement details the critical shareholder vote required to finalize an $80 million capital raise that closed on April 28, 2026. The raise was essential for the company to meet regulatory capital requirements and avoid formal enforcement action, following significant net losses and a non-well-capitalized bank subsidiary. Approval of these proposals will result in existing common shareholders owning only 15.24% of the company, representing an 84.76% dilution. The conversion price of $3.50 per share is a deep discount to the current market price. The company also plans a follow-on offering at the same discounted price, allowing existing shareholders to participate. This event is thesis-altering due to the extreme dilution and the fundamental restructuring required for the company's survival.